These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3459509

  • 1. The in vitro effects and cross-resistance patterns of some novel anthracyclines.
    Twentyman PR, Fox NE, Wright KA, Workman P, Broadhurst MJ, Martin JA, Bleehen NM.
    Br J Cancer; 1986 May; 53(5):585-94. PubMed ID: 3459509
    [Abstract] [Full Text] [Related]

  • 2. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.
    Coley HM, Twentyman PR, Workman P.
    Biochem Pharmacol; 1989 Dec 15; 38(24):4467-75. PubMed ID: 2604747
    [Abstract] [Full Text] [Related]

  • 3. Identification of anthracyclines and related agents that retain preferential activity over adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A.
    Coley HM, Twentyman PR, Workman P.
    Cancer Chemother Pharmacol; 1989 Dec 15; 24(5):284-90. PubMed ID: 2547527
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of adriamycin accumulation and effectiveness in adriamycin-resistant cells by aclacinomycin A.
    Tapiero H, Boulé D, Trincal G, Fourcade A, Lampidis TJ.
    Leuk Res; 1988 Dec 15; 12(5):411-8. PubMed ID: 3164087
    [Abstract] [Full Text] [Related]

  • 5. Drug resistance in human lung cancer cell lines: cross-resistance studies and effects of the calcium transport blocker, verapamil.
    Twentyman PR, Fox NE, Bleehen NM.
    Int J Radiat Oncol Biol Phys; 1986 Aug 15; 12(8):1355-8. PubMed ID: 3019960
    [Abstract] [Full Text] [Related]

  • 6. The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs--an in vitro study using EMT6 multicellular spheroids.
    Kwok TT, Twentyman PR.
    Int J Cancer; 1985 May 15; 35(5):675-82. PubMed ID: 3997287
    [Abstract] [Full Text] [Related]

  • 7. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M, Niimi S, Horichi N, Fukuda M, Saijo N.
    Cancer Res; 1989 Aug 01; 49(15):4098-102. PubMed ID: 2472873
    [Abstract] [Full Text] [Related]

  • 8. 9-alkyl anthracyclines. Absence of cross-resistance to adriamycin in human and murine cell cultures.
    Scott CA, Westmacott D, Broadhurst MJ, Thomas GJ, Hall MJ.
    Br J Cancer; 1986 May 01; 53(5):595-600. PubMed ID: 3718817
    [Abstract] [Full Text] [Related]

  • 9. Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.
    Coley HM, Twentyman PR, Workman P.
    Anticancer Drug Des; 1992 Dec 01; 7(6):471-81. PubMed ID: 1337431
    [Abstract] [Full Text] [Related]

  • 10. Cellular pharmacology of MX2, a new morpholino anthracycline, in human pleiotropic drug-resistant cells.
    Watanabe M, Komeshima N, Naito M, Isoe T, Otake N, Tsuruo T.
    Cancer Res; 1991 Jan 01; 51(1):157-61. PubMed ID: 1988080
    [Abstract] [Full Text] [Related]

  • 11. Antitumor activity of DA-125, a novel anthracycline, in human gastric and pulmonary adenocarcinoma cells resistant to adriamycin and cisplatin.
    Hong WS, Jung HY, Yang SK, Kim HR, Min YI.
    Anticancer Res; 1997 Jan 01; 17(5A):3613-6. PubMed ID: 9413212
    [Abstract] [Full Text] [Related]

  • 12. Relationship between the intracellular accumulation of anthracyclines and effectiveness in vitro and in vivo.
    Tapiero H, Munck JN, Fourcade A.
    Drugs Exp Clin Res; 1986 Jan 01; 12(1-3):257-64. PubMed ID: 3460752
    [Abstract] [Full Text] [Related]

  • 13. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1984 Mar 01; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [Abstract] [Full Text] [Related]

  • 14. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
    Tanaka N.
    Gan To Kagaku Ryoho; 1984 Dec 01; 11(12 Pt 2):2666-73. PubMed ID: 6210060
    [Abstract] [Full Text] [Related]

  • 15. Use of a tritiated thymidine suicide technique in the study of the cytotoxic drug response of cells located at different depths within multicellular spheroids.
    Kwok TT, Twentyman PR.
    Br J Cancer; 1987 Apr 01; 55(4):367-74. PubMed ID: 3034319
    [Abstract] [Full Text] [Related]

  • 16. Establishment and characterization of an adriamycin-resistant subline of human small cell lung cancer cells.
    Miyamoto H.
    Acta Med Okayama; 1986 Apr 01; 40(2):65-73. PubMed ID: 3012965
    [Abstract] [Full Text] [Related]

  • 17. Cross-resistance to tumour promoters in human cancer cell lines resistant to adriamycin or cisplatin.
    Nishio K, Sugimoto Y, Nakagawa K, Niimi S, Fujiwara Y, Bungo M, Kasahara K, Fujiki H, Saijo N.
    Br J Cancer; 1990 Sep 01; 62(3):415-9. PubMed ID: 2206949
    [Abstract] [Full Text] [Related]

  • 18. A close association of adriamycin resistance with expression of cell surface antigens in adriamycin-resistant cell lines of herpes simplex virus type 2-transformed Syrian hamster cells.
    Kimura S, Okazaki K.
    Jpn J Cancer Res; 1985 Dec 01; 76(12):1179-85. PubMed ID: 3005209
    [Abstract] [Full Text] [Related]

  • 19. The response to cytotoxic drugs of EMT6 cells treated either as intact or disaggregated spheroids.
    Kwok TT, Twentyman PR.
    Br J Cancer; 1985 Feb 01; 51(2):211-8. PubMed ID: 3966978
    [Abstract] [Full Text] [Related]

  • 20. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K, Kunimoto S, Takeuchi T.
    Biomed Pharmacother; 1987 Feb 01; 41(5):206-13. PubMed ID: 2444279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.